Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Wenting

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
European Heart Journal|December 1, 1990
First passage radionuclide cardiography for determination of cardiac output: a critical analysisG J Wenting, R M Brouwer, A J Man In 't Veld, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumesG J Wenting, A J Man in 't Veld, F H Derkx, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertensionA J Man in 't Veld, G J Wenting, R P Verhoeven, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1992
Modeling blood pressure profilesR N Idema, E S Gelsema, G J Wenting, et al.
Transplantation|November 1, 1989
Amelioration of preservation damage but not cyclosporine nephrotoxicity by dihydroergotoxine in kidney transplant recipients. A double-blind placebo-controlled trialM L Brouwer, G J Wenting, H H Vincent, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Ketanserin: a possible tool for studying the role of serotonin in hypertensionA J Woittiez, G J Wenting, A J Man in't Veld, et al.
Transplantation|August 1, 1989
Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejectionH J Metselaar, P H Rothbarth, R M Brouwer, et al.
Transplantation Proceedings|February 1, 1987
T cell subset analysis predicts virus infection but not rejection in cyclosporine A-treated renal allograft recipientsH J Metselaar, J Jeekel, P H Rothbarth, et al.
Transplantation|September 1, 1987
Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and whyD J Versluis, G J Wenting, F H Derkx, et al.
British Journal of Clinical Pharmacology|May 1, 1982
Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in manH H Vincent, A J Man In't Veld, F Boomsma, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
European Heart Journal|December 1, 1990
First passage radionuclide cardiography for determination of cardiac output: a critical analysisG J Wenting, R M Brouwer, A J Man In 't Veld, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumesG J Wenting, A J Man in 't Veld, F H Derkx, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertensionA J Man in 't Veld, G J Wenting, R P Verhoeven, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1992
Modeling blood pressure profilesR N Idema, E S Gelsema, G J Wenting, et al.
Transplantation|November 1, 1989
Amelioration of preservation damage but not cyclosporine nephrotoxicity by dihydroergotoxine in kidney transplant recipients. A double-blind placebo-controlled trialM L Brouwer, G J Wenting, H H Vincent, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Ketanserin: a possible tool for studying the role of serotonin in hypertensionA J Woittiez, G J Wenting, A J Man in't Veld, et al.
Transplantation|August 1, 1989
Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejectionH J Metselaar, P H Rothbarth, R M Brouwer, et al.
Transplantation Proceedings|February 1, 1987
T cell subset analysis predicts virus infection but not rejection in cyclosporine A-treated renal allograft recipientsH J Metselaar, J Jeekel, P H Rothbarth, et al.
Transplantation|September 1, 1987
Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and whyD J Versluis, G J Wenting, F H Derkx, et al.
British Journal of Clinical Pharmacology|May 1, 1982
Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in manH H Vincent, A J Man In't Veld, F Boomsma, et al.
Pageof 8